Keywords: Stroke; Antiepileptic drugs; Drug-drug interaction; Statins; Calcium channel blockers; Anticoagulants; AED; antiepileptic drug; EIAED; enzyme-inducer AED; NEIAED; non-EIAED; CCB; calcium-channel blocker; NOAC; non-vitamin K antagonist oral anticoagulant;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: DI; diisocyanate; DDI; 4, 4 diphenyl diisocyanate; HDI; 1, 6 hexamethylene diisocyanate; Bioplastic; Crosslinking; Agar; Cytocompatibility; Hemocompatibility;
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMPAR; AMPA receptor; AP5; 2-amino-5-phosphonopentanoic acid; ATPA; (RS)-2-Amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid; AUC; area under the curve; CNS; central nervous system; C
Keywords: AOX; aldehyde oxidase; AUC; area under the plasma concentration time curve; CYP; cytochrome P450; DDI; drug-drug interaction; LC; liquid chromatography; MBE; minimum binding energy; MS/MS; tandem mass spectrometry; ESI; electrospray ionization; PK; phar
Keywords: ADAM; advanced dissolution, absorption, and metabolism; AED; antiepileptic drug; AUC; area-under-the-curve; B/P; blood to plasma ratio; BID; twice daily; BMI; body mass index; CBZ; carbamazepine; CLint; intrinsic clearance; CLR; renal clearance; CL; clear
Keywords: CNS; central nervous system; DDI; Dasman Diabetes Institute; EDSS; expanded disability status scale; ELISA; Enzyme-Linked Immunosorbent Assay; HC; healthy controls; HRP; Horseradish peroxidase; MS; Multiple Sclerosis; MSSS; Multiple Sclerosis Severity Sca
Keywords: carbonyl reductase 1; tissue distribution; liver; intestine; kidney; LC-MS/MS; protein quantification; proteomics; CBR; carbonyl reductase; DDI; drug-drug interactions; DMF; dimethylformamide; fm; fraction metabolized; IDA; information-dependent acquisiti
Keywords: Acyl glucuronide; Drug development; Drug toxicity; In vitro screening; In vivo model; Immune activation; Protein adduct; Reactive metabolite; UDP-glucuronosyltransferase; ADR; adverse drug reaction; AG; acyl glucuronide; AGE; advanced glycation end prod
Keywords: plasma protein binding; fraction unbound; drug-drug interaction; AUC; area under the curve; AUCR; area under the curve ratio; AAG; alpha 1-acid glycoprotein; CYP; cytochrome P450; BSA; bovine serum albumin; CRO; contract research organization; CV; coeffic
Keywords: BSA; bovine serum albumin; CYP; cytochrome P450; DDI; drug-drug interaction; DME; drug metabolizing enzyme; GST; glutathione-S-transferase; HLM; human liver microsomes; HSA; human serum albumin; NAT; N-acetyltransferase; NSAID; non-steroidal anti-inflamma
Keywords: drug interaction; cytochrome P450s; membrane transport/transporters; substrate; inhibitor; inducer; AE; adverse event; CYP; cytochrome P-450; DDI; drug-drug interaction; E-R; exposure-response; FDA; Food and Drug Administration; PK; pharmacokinetic;
Keywords: EHR; electronic health record; UCD; user-centered design; DDI; drug-drug interactions; HIBA; Hospital Italiano de Buenos Aires; CPOE; computerized physician order entry; HIMSS; Healthcare Information and Management Systems Society; TD; traditional design;
Keywords: physiologically based pharmacokinetic modeling; drug interactions; Monte Carlo; in vitro-in vivo correlations (IVIVC); nonlinear regression; biliary excretion; biliary recycling; hepatic metabolism; hepatic transport; AUC; area under the curve of concen
Keywords: Natural products; Dietary supplements; Herbal medicines; Drug interactions; Cytochrome P450; Transporters; Metabolic enzymes; CYP450; cytochrome P450; Cmax; maximum concentration; DDI; drug-drug interactions; MDP; methylenedioxyphenyl; NP; natural produ
Keywords: structure property relationships; molecular modeling; organic anion-transporting polypeptide transporters; drug interactions; 2D; two dimensional; 3D; three dimensional; DDI; drug-drug interaction; HEK cells; human embryonic kidney cells; IC50; inhibition
Keywords: in silico modeling; QSAR; transporters; computational ADME; high-throughput technologies; AUC; area under the curve; BCRP; breast cancer resistance protein; DDI; drug-drug interaction; fup; protein unbound fraction in plasma; ITC; International Transpor
Keywords: ACR; albumin/creatinine ratio; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BMI; body mass index; BUN; blood urea nitrogen; DBP; diastolic blood pressure; DEHP; di-(2-ethylhexyl) phthalate; DDI; daily DEHP intake; DINP; di-isononyl phth
Keywords: CS; Caesarean section; DDI; Decision to delivery interval; GP; General Practitioner; MGP; Midwifery Group Practice; NMSCF; Australian National Maternity Services Capability Framework; NMSP; National Maternity Services Plan; SMO; Senior Medical Officer; Ru
Keywords: AAV; Adeno associated virus; ABC; ATP-binding cassette; ACMG; American College Medical Genetics; AH; Ancestral Haplotype; ASL; airway surface liquid; ATP; Adenosine triphosphate; cas; CRISPR associated; CF; Cystic fibrosis; CFTR; Cystic Fibrosis Transmemb
Keywords: Intracellular drug concentration; Pharmacodynamics; OCT; MATE; PMAT; Drug transporter; ABC; ATP-binding cassette; ACC; acetyl-CoA carboxylase; AMP; adenosine monophosphate; AMPK; AMP-activated protein kinase; AUC; area under the concentration time curve;
Keywords: AUC; area under the plasma concentration-time curve; B/P; blood-to-plasma ratio; CYP; cytochrome P450; CLint; intrinsic clearance; Cmax; maximum plasma concentration; CLPD; passive permeability-surface area product; DDI; drug-drug interaction; fa; fract
Keywords: Statin; Adverse effects; Drug-drug interactions; Pharmacogenetics; ABC; ATP-binding cassette; ASCVD; atherosclerotic cardiovascular disease; CPIC; Clinical Pharmacogenetic Implementation Consortium; CK; creatinine kinase; CV; cardiovascular; CVD; cardio
Keywords: Bosentan; Perfluorinated analogues; Metabolic specificity; Phase I metabolism; HLM; Cl; Clearance; CYP; Cytochrome P450; DDI; drug-drug interactions; ERA; Endothelin Receptor Antagonist; ET-1; Endothelin 1; ETA; Endothelin receptor A; ETB; Endothelin rece
Keywords: DDI; 7,8-dimethyl-10-dodecyl isoalloxazine; Flavin; Langmuir-Blodgett; Isoalloxazine; Extended dipole model; Exciton coupling theory; I-type aggregation;
Keywords: Thymidine kinase 2; Deoxyguanosine kinase; Nucleoside analogs; ddI; Mitochondrial toxicity;
Keywords: HCV; hepatitis C; LT; liver transplantation; DDI; drug-drug interactions; DAAs; direct-acting antivirals; PegINF; peginterferon; RBV; ribavirin; MELD; model of end-stage liver disease; PI; protease inhibitor; PR; peginterferon plus ribavirin; SAEs; seriou
Keywords: ADMET; absorption, distribution metabolism, elimination, toxicity; API; active pharmaceutical ingredient; BS; bilesalt; BS/PL; bile salt to phospholipid ratio; CMC; critical micellar concentration; DDI; drug-drug interaction; FaSSGF; fasted state simula
Keywords: 5FU; 5-fluorouracile; ABC; ATP-binding cassette; AUC; area under the curve; BCRP; breast cancer resistance protein; Cmax; maximum (peak) plasma concentration; CYP; cytochrome p450 enzymes; DDI; drug-drug interactions; EIAEDS; enzyme-inducing antiepilept
Keywords: DAT; days after transplanting; DDI; double drip irrigation; SDI; single drip irrigation; SSD; subsurface drip irrigation; FI; furrow irrigation; BG; β-glucosidase; GWC; gravimetric water content; EC; electrical conductivity; FDA; fluorescein diacetate; N
A UHPLC-MS/MS method coupled with liquid-liquid extraction for the quantitation of phenacetin, omeprazole, metoprolol, midazolam and their metabolites in rat plasma and its application to the study of four CYP450 activities
Keywords: ACE; acetaminophen; PHE; phenacetin; OHOME; 5â²-hydroxy omeprazole; OME; omeprazole; OHMET; α-hydroxy metoprolol; MET; metoprolol; OHMDZ; 1â²-hydroxy midazolam; MDZ; midazolam; CYP450; Probe drug; Metabolite; UHPLC-MS/MS; DDI; 3-n-butylphthalide;
Herb-drug interaction of Nisha Amalaki and Curcuminoids with metformin in normal and diabetic condition: A disease system approach
Keywords: NA; Nisha Amalaki; CE; Curcuminoids; MET; metformin; DDI; drug-drug interactions; HDI; herb-drug interactions; CYPs; cytochrome p450 isoenzymes; IS; internal standard; MWR; Male Wistar rats; STZ; streptozotocin; MNC; mononuclear cells; OCT; organic cation
Co-administration with simvastatin or lovastatin alters the pharmacokinetic profile of sinomenine in rats through cytochrome P450-mediated pathways
Keywords: RA; rheumatoid arthritis; CV; cardiovascular; CYP enzyme; cytochrome P450 enzyme; DDI; drug-drug interaction; RLMs; rat liver microsomes; IS; internal standard; Sinomenine (PubChem CID: 5459308); Simvastatin (PubChem CID: 54454); Lovastatin (PubChem CID:
A rapid and simple HPLC-MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients
Keywords: VPA; valproic acid; UGT; uridine diphosphate glucuronosyltransferases; HPLC; MS/MS high performance liquid chromatography tandem mass spectrometry; HPLC; high-performance liquid chromatography; GC-MS; gas chromatograph tandem mass spectrometry; SRM; sel
Enzyme production by a fungoid marine protist, Thraustochytrium striatum
Keywords: ASW; artificial sea water; CMC; carboxymethyl cellulose; DCM; dry cell mass; DHA; docosahexaenoic acid; EPA; eicosapentaenoic acid; EPS; extracellular polymeric substances; DDI; deionized distilled water; MWCO; molecular weight cutoff; NAG-N; acetyl-d-glu
Comprehensive Study of Cultivation Conditions and Methods on Lipid Accumulation of a Marine Protist, Thraustochytrium striatum
Keywords: ASW; artificial sea water; DCM; dry cell mass; DHA; docosahexaenoic acid; EPA; eicosapentaenoic acid; DPA; docosapentaenoic acid; ARA; arachidonic acid; FAME; fatty acid methyl ester; LC-PUFA; long chain polyunsaturated fatty acid; DDI; deionized distille
Recomendaciones de GESIDA/PETHEMA sobre el diagnóstico y tratamiento de los linfomas en pacientes infectados por el virus de la inmunodeficiencia humana
Keywords: Linfoma no hodgkiniano; Linfoma de Hodgkin; VIH; Sida; Tratamiento antirretroviral; Non-Hodgkin's lymphoma; Hodgkin's lymphoma; HIV; AIDS; Antiretroviral therapy; ABC; abacavir; ABVD; adriamicina, bleomicina, vinblastina y dacarbazina; Ara-C; arabinósido
Repeated administration of Sailuotong, a fixed combination of Panax ginseng, Ginkgo biloba, and Crocus sativus extracts for vascular dementia, alters CYP450 activities in rats
Keywords: Sailuotong; Panax ginseng; Ginkgo biloba; Crocus sativus; CYP450; Herb-drug interaction; Abbreviation: SLT; Sailuotong; VD; vascular dementia; TCM; traditional Chinese medicines; DDI; drug-drug interaction; CYP450; cytochrome P450; SPE; solid phase extrac
P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats
Keywords: AUC; area under the plasma concentration-time curve; BEI; biliary excretion index; CsA; cyclosporin A; DDI; drug-drug interaction; LC-MS/MS; liquid chromatography-tandem mass spectrometry; MDCKII cells; Madin-Darby canine kidney strain II cells; N
Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro
Keywords: 95%CI; 95% confidential interval; AB; apical-to-basolateral; ABC; ATP-binding cassette; Abcb1; canine P-glycoprotein; ABCB1; human P-glycoprotein; ABCC1; multidrug resistance-associated protein 1; ABCG2; breast cancer resistance protein; BA; basolateral-t
Characterization of CYP2C Induction in Cryopreserved Human Hepatocytes and Its Application in the Prediction of the Clinical Consequences of the Induction
Keywords: cytochrome P450; mathematical models; hepatocytes; drug-drug interaction; induction; CAR; constitutive androstane receptor; CITIO; 6-(4-clorophenyl) imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime; P450; cytochrome P450; DDI; drug-d
Development of controlled release amorphous solid dispersions (CRASD) using polyvinyl acetate-based release retarding materials: Effect of dosage form design
Keywords: ASD; amorphous solid dispersion; ATR; attenuated total reflectance; AUC; area under the curve; BCS; Biopharmaceutic Classification System; CEL; celecoxib; Cmax; maximum concentration, or peak kinetic solubility; CR; controlled release; CRASD; controlled r
Design and optimization of the cocktail assay for rapid assessment of the activity of UGT enzymes in human and rat liver microsomes
Keywords: Estradiol (PubChem CID: 5757); Chenodeoxycholic acid (PubChem CID: 10133); Serotonin (PubChem CID: 5202); Propofol (PubChem CID: 4943); Zidovudine (PubChem CID: 35370); CYP; cytochrome P450; UGT; UDP-glucuronosyltransferases; DDI; drug-drug interactions;
Cell cultures in drug discovery and development: The need of reliable in vitro-in vivo extrapolation for pharmacodynamics and pharmacokinetics assessment
Keywords: 3Rs; Reduction, Replacement, Refinement; PBPK; physiologically based pharmacokinetic; 2D; two-dimensional; 3D; three-dimensional; HTS; high-throughput screening; IVIVE; in vitro-in vivo extrapolation; ADME; absorption, distribution, metabolism and excreti
Imaging techniques to study drug transporter function in vivo
Keywords: ABC; ATP-binding cassette; AD; Alzheimer's disease; ADME; absorption, distribution, metabolism and elimination; ATP; adenosine triphosphate; AUC; area under the curve; BBB; blood-brain barrier; BCRP; breast cancer resistance protein; BPND; non-displaceabl
Electrical pulse stimulation decreases electrochemical Na+ and K+ gradients in C2C12 myotubes
Keywords: Electrical pulse stimulation; Electrical stimulation; Na+ K+ gradients; C2C12 myotubes; Ouabain; EPS; electrical pulse stimulation; DMEM; Dulbecco's Modified Eagle's Medium; FBS; fetal bovine serum; PBST; PBS supplemented with Tween 20; DDI; doubly deioni
Tenofovir alafenamide (TAF) does not deplete mitochondrial DNA in human T-cell lines at intracellular concentrations exceeding clinically relevant drug exposures
Keywords: Mitochondrial toxicity; mtDNA synthesis; T-cells; NRTI; TAF; Tenofovir alafenamide; d4T; stavudine; ddC; dideoxycytidine; ddI; dideoxyinosine; NRTI; nucleoside reverse transcriptase inhibitor; PBMC; peripheral blood mononuclear cell; TAF; tenofovir alafen
Redox regulation of proteasome function
Keywords: Abcd1; ATP binding cassette subfamily D member 1; AD; Alzheimer's disease; ALD; adrenoleukodystrophy; ALS; amyotrophic lateral sclerosis; AP-1; activator protein-1; APP; amyloid precursor protein; CNS; central nervous system; DDI; DNA-damage inducible 1;
Effects of diosmetin on nine cytochrome P450 isoforms, UGTs and three drug transporters in vitro
Keywords: Diosmetin; Cytochrome P450; UDP-glucuronyltransferases; Hepatic uptake transporters; Drug-drug interactions; CYPs; Cytochrome P450 enzymes; DDI; drug-drug interactions; HDI; herb-drug interactions; HLMs; human liver microsomes; NTCP; Na+-taurocholate cotr
Supplemental Analysis of the Prediction of Hepatic Clearance of Binary Mixtures of Bisphenol A and Naproxen Determined in an Isolated Perfused Rat Liver Model to Promote the Understanding of Potential Albumin-Facilitated Hepatic Uptake Mechanism
Keywords: albumin-mediated uptake; clearance; DDI; drug interaction; hepatocytes; IVIVE; IPRL; pharmacokinetics; PBPK models;
Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population
Keywords: TB; tuberculosis; ADR; adverse drug reaction; ATDH; Anti-TB drug-induced hepatotoxicity; DDI; drug-drug interaction; HIV; human immunodeficiency virus; NAT2; N-acetyltransferase 2; CYP; cytochrome P450; GST; glutathione S-transferase; ALT; alanine aminotr